Guideline Central Blog

Approved Drugs

Upcoming FDA Approvals & Decisions

Upcoming FDA Decisions – October 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Upcoming FDA Approvals & Decisions - September 2024

Upcoming FDA Decisions – September 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Upcoming FDA Approvals & Decisions

Upcoming FDA Decisions – August 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Upcoming FDA Approvals & Decisions - July 2024

Upcoming FDA Decisions – July 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Upcoming FDA Approvals & Decisions - June 2024

Upcoming FDA Decisions – June 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Upcoming FDA Decisions – May 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug or device applications. Below, you will find a list of drugs and devices, […]

Clinical Guideline Alerts & FDA Drug Approvals Hero Image

New Clinical Practice Guidelines & FDA Drug Approvals – September 2023

Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia Author:American College of Obstetricians and Gynecologists (ACOG) Published:September 1, 2023 Outpatient Treatment of Confirmed COVID-19 Author:American College of Physicians (ACP) Published:September 19, 2023 Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis with Secondary Arthritis […]

Clinical Guideline Alerts Banner

New Clinical Practice Guidelines & FDA Drug Approvals – August 2023

Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication Author:United States Preventive Services Task Force (USPSTF) Published:August 2023 Prevention of Acquisition of HIV: Preexposure Prophylaxis Author:United States Preventive Services Task Force (USPSTF) Published:August 2023 Palliative Care for People with Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease Author:European Respiratory Society (ERS) Published:August 17, 2023 […]

New Clinical Practice Guidelines & FDA Drug Approvals – July 2023

Lipid Disorders in Children and Adolescents: Screening Author:United States Preventive Services Task Force (USPSTF) Published:July 2023 Implementing Strategies to Prevent Infections in Acute-Care Settings Author:Infectious Diseases Society of America (IDSA); Society for Healthcare Epidemiology of America America (SHEA) Published:July 11, 2023 Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Author:American Society of Clinical Oncology (ASCO) […]

New Clinical Practice Guidelines & FDA Drug Approvals – June 2023

Anxiety Disorders in Adults: Screening – Adults 64 Years or Younger Author:United States Preventive Services Task Force (USPSTF) Published:June 2023 Anxiety Disorders in Adults: Screening – Older Adults 65 Years or Older Author:United States Preventive Services Task Force (USPSTF) Published:June 2023 Depression and Suicide Risk in Adults: Screening – Adults 64 Years or Younger Author:United […]

New Clinical Practice Guidelines & FDA Drug Approvals – May 2023

Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity Society:American Association of Clinical Endocrinologists (AACE) Published:May 4, 2023 Health Advisory on Social Media Use in Adolescence Society:American Psychological Association (APA) Published:May 9, 2023 2023 Comprehensive Type 2 Diabetes Management […]

New Clinical Guidelines & FDA Drug Approvals – April 2023

Skin Cancer: Screening Society:U.S. Preventative Services Task Foce (USPSTF) Published:April 18, 2023 COVID-19 Guideline Part 1: Treatment and Management Society:Infectious Diseases Society of America (IDSA) Published:April 13, 2023 Use of Antiretroviral Agents in Pediatric HIV Infection Society:United States Department of Health and Human Services (DHHS) Published:April 12, 2023 Management of REM Sleep Behavior Disorder Society:American […]

Clinical Guidelines Alert March 2023 Hero Image

New Clinical Guidelines & FDA Drug Approvals – March 2023

Probiotics and Prebiotics Society:World Gastroenterology Organisation (WGO) Published:March 1, 2023 Obesity Algorithm 2023 Society:Obesity Medicine Association (OMA) Published:March 1, 2023 Colorectal Cancer Screening Guidelines Toolkit Society:Consensus and Physician Experts (CPE) Published:March 1, 2023 COVID-19 Guideline, Part 1: Treatment and Management Society:Infectious Diseases Society of America (IDSA) Published:March 14, 2023 Comprehensive Adult Eye and Vision Examination […]

New Clinical Guidelines & FDA Drug Approvals – February 2023

Genital Herpes Infection: Serologic Screening Society:U.S. Preventive Services Task Force (USPSTF) Published:February 2023 Management of Patients With Acute Lower Gastrointestinal Bleeding Society:American College of Gastroenterology (ACG) Published:February 6, 2023 Strategies to Prevent Healthcare-Associated Infections: Hand Hygiene Society:Infectious Diseases Society of America (IDSA); Society for Healthcare Epidemiology of America (SHEA) Published:February 8, 2023 Disorders of Lipid […]

New Clinical Guidelines & FDA Drug Approvals – January 2023

Immunotherapy & Targeted Therapy for Advanced Gastroesophageal Cancer Society:American Society of Clinical Oncology (ASCO) Published:January 5, 2023 Vaccinations in Patients with Rheumatic & Musculoskeletal Diseases Society: American College of Rheumatology (ACR) Published:January 4, 2023 Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults Society:American College of Physicians (ACP) Published:January 3, […]

New Clinical Guidelines & FDA Drug Approvals – December 2022

Antiretroviral Drugs for Treatment & Prevention of HIV Infection in Adults Society:International Antiviral Society–USA (IAS-USA) Published:December 1, 2022 Standards of Care in Diabetes – 2023 Society: American Diabetes Association (ADA) Published:December 12, 2022 Interventional Treatments for Low Back Pain Society:American Society of Pain and Neuroscience (IASPN) Published:December 6, 2022 Monitoring and Antagonism of Neuromuscular Blockade […]

New Clinical Guidelines & FDA Drug Approvals – November 2022

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 Society:Centers for Disease Control and Prevention (CDC) Published:November 4, 2022 Clinical Assessment of Patients with Inherited Retinal Degenerations Society: American Academy of Ophthalmology (AAO) Published:November 1, 2022 Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science Society:International Liaison Committee on Resuscitation (ILCOR) Published:November 3, […]

National Diabetes Month 2022 – What’s New in Clinical Guidelines for Diabetes Awareness Month

November is Diabetes Awareness Month or National Diabetes Month. In this article, we will take a look at all of the new guidelines, therapies and innovations that have been introduced since Diabetes Awareness Month 2021.  Guidelines Below is a list of various Diabetes-related clinical practice guidelines that were published between National Diabetes Month 2021 and […]

New Clinical Guidelines & FDA Drug Approvals – October 2022

Treatment of Metastatic Colorectal Cancer Society:American Society of Clinical Oncology (ASCO) Published:October 17, 2022 Pharmacological Interventions for Adults With Obesity Society:American Gastroenterological Association (AGA) Published:October 20, 2022 Drug Allergy (2022 Update) Society:American College of Allergy, Asthma, & Immunology (ACAAI) & American Academy of Allergy, Asthma, & Immunology (AAAI) Published:October 3, 2022 Diabetes Management in Chronic […]

Top 7 Most Unusually Specific Clinical Guidelines – 2022 Edition

As most know, clinical guidelines are meant to translate the best available evidence into the best available clinical practice. The best available evidence is commonly in the form of randomized controlled trials (RCTs), and most RCTs study homogenous populations. This of course makes sense, because the trials want to be as controlled as possible and […]